Kehua Biotech announced that Suzhou Tianlong Biotechnology Co., Ltd., a holding subsidiary of the company, has received a medical device registration certificate issued by the State Drug Administration. The product is influenza A/B and respiratory syncytial virus nucleic acid detection kit. The registration certificate number is Guohuangzhu 20263401882. The validity period is from September 4, 2026 to September 3, 2031, to qualitatively test influenza A, influenza B and respiratory syncytial virus nucleic acid in human throat swab samples. The acquisition of this registration certificate has enriched the company's product line and had a positive impact on the company's business development.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.